2024 ICD-10-CM Diagnosis Code T47.1X5
Adverse effect of other antacids and anti-gastric-secretion drugs
- ICD-10-CM Code:
- T47.1X5
- ICD-10 Code for:
- Adverse effect of antacids and anti-gastric-secretion drugs
- Is Billable?
- Not Valid for Submission
- Code Navigator:
T47.1X5 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of adverse effect of other antacids and anti-gastric-secretion drugs. The code is not specific and is NOT valid for the year 2024 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.
Specific Coding Applicable to Adverse effect of antacids and anti-gastric-secretion drugs
Non-specific codes like T47.1X5 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10-CM codes with a higher level of specificity when coding for adverse effect of antacids and anti-gastric-secretion drugs:
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Adverse reaction to alexitol sodium
- Adverse reaction to aluminum and/or aluminum compound
- Adverse reaction to aluminum and/or aluminum compound
- Adverse reaction to aluminum and/or aluminum compound
- Adverse reaction to aluminum and/or aluminum compound
- Adverse reaction to aluminum and/or aluminum compound
- Adverse reaction to calcium carbonate and/or etidronic acid
- Adverse reaction to hydrotalcite
- Adverse reaction to magaldrate
- Adverse reaction to magnesium carbonate
- Adverse reaction to oxytocic agents
- Adverse reaction to sodium bicarbonate
- Aluminum hydroxide adverse reaction
- Antacid adverse reaction
- Antacid bezoar
- Carbenoxolone adverse reaction
- Dimethicone adverse reaction
- Lansoprazole adverse reaction
- Magnesium trisilicate adverse reaction
- Medication bezoar
- Misoprostol adverse reaction
- Omeprazole adverse reaction
- Pirenzepine adverse reaction
- Proton pump inhibitor adverse reaction
- Sucralfate adverse reaction
- Terpenes adverse reaction
Clinical Information
Burimamide
an antagonist of histamine that appears to block both h2 and h3 histamine receptors. it has been used in the treatment of ulcers.Carbenoxolone
an agent derived from licorice root. it is used for the treatment of digestive tract ulcers, especially in the stomach. antidiuretic side effects are frequent, but otherwise the drug is low in toxicity.Enprostil
a synthetic pge2 analog that has an inhibitory effect on gastric acid secretion, a mucoprotective effect, and a postprandial lowering effect on gastrin. it has been shown to be efficient and safe in the treatment of gastroduodenal ulcers.Metiamide
a histamine h2 receptor antagonist that is used as an anti-ulcer agent.Misoprostol
a synthetic analog of natural prostaglandin e1. it produces a dose-related inhibition of gastric acid and pepsin secretion, and enhances mucosal resistance to injury. it is an effective anti-ulcer agent and also has oxytocic properties.Omeprazole
a 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of stomach ulcers and zollinger-ellison syndrome. the drug inhibits an h(+)-k(+)-exchanging atpase which is found in gastric parietal cells.Pirenzepine
an antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. it promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. it also potentiates the effect of other antiulcer agents such as cimetidine and ranitidine. it is generally well tolerated by patients.Proglumide
a drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. it is used clinically in the drug therapy of gastrointestinal ulcers.Simethicone
a poly(dimethylsiloxane) which is a polymer of 200-350 units of dimethylsiloxane, along with added silica gel. it is used as an antiflatulent, surfactant, and ointment base.Sucralfate
a basic aluminum complex of sulfated sucrose.
Coding Guidelines
When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate code for the adverse effect of the drug.
The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of agents primarily affecting the gastrointestinal system (T47). Use the following options for the aplicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
Table of Drugs and Chemicals
The code is referenced in the Table of Drugs and Chemicals, this table contains a classification of drugs, industrial solvents, corrosive gases, noxious plants, pesticides, and other toxic agents.
According to ICD-10-CM coding guidelines it is advised to do not code directly from the Table of Drugs and Chemicals, instead always refer back to the Tabular List when doing the initial coding. Each substance in the table is assigned a code according to the poisoning classification and external causes of adverse effects. It is important to use as many codes as necessary to specify all reported drugs, medicinal or chemical substances. If the same diagnosis code describes the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, utilize the code only once.
Patient Education
Drug Reactions
Most of the time, medicines make our lives better. They reduce aches and pains, fight infections, and control problems such as high blood pressure or diabetes. But medicines can also cause unwanted reactions, such as drug interactions, side effects, and allergies.
What is a drug interaction?
A drug interaction is a change in the way a drug acts in the body when taken with certain other drugs, foods, or supplements or when taken while you have certain medical conditions. Examples include:
- Two drugs, such as aspirin and blood thinners
- Drugs and food, such as statins and grapefruit
- Drugs and supplements, such as gingko and blood thinners
- Drugs and medical conditions, such as aspirin and peptic ulcers
Interactions could cause a drug to be more or less effective, cause side effects, or change the way one or both drugs work.
What are side effects?
Side effects are unwanted, usually unpleasant, effects caused by medicines. Most are mild, such as a stomachache, dry mouth, or drowsiness, and go away after you stop taking the medicine. Others can be more serious. Sometimes a drug can interact with a disease that you have and cause a side effect. For example, if you have a heart condition, certain decongestants can cause you to have a rapid heartbeat.
What are drug allergies?
Drug allergies are another type of reaction. They can range from mild to life-threatening. Skin reactions, such as hives and rashes, are the most common type. Anaphylaxis, a serious allergic reaction, is less common.
How can I stay safe when taking medicines?
When you start a new prescription or over-the-counter medicine, make sure you understand how to take it correctly. Know which other medicines, foods, and supplements you need to avoid. Always talk to your health care provider or pharmacist if you have questions about your medicines.
[Learn More in MedlinePlus]
Code History
- FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.